Search Results
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Mette Marie Baunsgaard in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Sophie Lind Helligsoe in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Louise Tram Henriksen in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Torben Stamm Mikkelsen in
Google Scholar
PubMed
Search for other papers by Michael Callesen in
Google Scholar
PubMed
Search for other papers by Britta Weber in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Henrik Hasle in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Niels Birkebæk in
Google Scholar
PubMed
physical chronic late effects ( 15 ) with growth hormone deficiency (GHD) being the most common endocrinopathy ( 16 ) followed by thyroid-stimulating hormone deficiency ( 17 ). CR is the most significant risk factor for the development of GHD ( 18
Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Ken K Y Ho in
Google Scholar
PubMed
Search for other papers by Bradley S Miller in
Google Scholar
PubMed
Search for other papers by Ignacio Bergada in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
Introduction Growth hormone deficiency (GHD) is a clinical syndrome that can present either as isolated GHD or associated with additional pituitary hormone deficiencies in children and adults. Childhood-onset GHD (CO-GHD) is often idiopathic
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by Andrew A Toogood in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Neil Gittoes in
Google Scholar
PubMed
Search for other papers by Anne Topping in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Niki Karavitaki in
Google Scholar
PubMed
Introduction Growth hormone deficiency (GHD) is a clinical condition that can present in childhood or adult life. Adult-onset GHD is usually caused by a pituitary tumour and/or its treatments (surgery, radiotherapy) ( 1 ). Although the true
Search for other papers by Xiaonan Guo in
Google Scholar
PubMed
Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Search for other papers by Xiaorui Lyu in
Google Scholar
PubMed
Search for other papers by Hanyuan Xu in
Google Scholar
PubMed
Search for other papers by Huijuan Zhu in
Google Scholar
PubMed
Search for other papers by Hui Pan in
Google Scholar
PubMed
Search for other papers by Linjie Wang in
Google Scholar
PubMed
Search for other papers by Hongbo Yang in
Google Scholar
PubMed
Search for other papers by Fengying Gong in
Google Scholar
PubMed
and lipid metabolism, including glucose production, the uptake and storage of lipids, and the secretion of triglycerides ( 3 ). Growth hormone deficiency (GHD) is a relatively uncommon endocrine disease caused by a primary deficiency of GH and a
Search for other papers by Lukas Plachy in
Google Scholar
PubMed
Search for other papers by Petra Dusatkova in
Google Scholar
PubMed
Search for other papers by Klara Maratova in
Google Scholar
PubMed
Search for other papers by Shenali Anne Amaratunga in
Google Scholar
PubMed
Search for other papers by Dana Zemkova in
Google Scholar
PubMed
Search for other papers by Vit Neuman in
Google Scholar
PubMed
Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed
Search for other papers by Barbora Obermannova in
Google Scholar
PubMed
Search for other papers by Marta Snajderova in
Google Scholar
PubMed
Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed
Search for other papers by Jan Lebl in
Google Scholar
PubMed
Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed
Introduction Combined pituitary hormone deficiency (CPHD) is characterized by growth hormone deficiency (GHD) associated with a shortage of at least one other pituitary hormone ( 1 ). The etiology of CPHD is complex, including acquired
Search for other papers by Jelena Stankovic in
Google Scholar
PubMed
Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Kurt Kristensen in
Google Scholar
PubMed
Search for other papers by Niels Birkebæk in
Google Scholar
PubMed
Search for other papers by Jens Otto Lunde Jørgensen in
Google Scholar
PubMed
Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Esben Søndergaard in
Google Scholar
PubMed
BMK Radovick S Carmichael JD Jasim S Pantalone KM & Hoffman AR . American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients
Search for other papers by Izabelle Lövgren in
Google Scholar
PubMed
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
Search for other papers by Azadeh Abravan in
Google Scholar
PubMed
Search for other papers by Abigail Bryce-Atkinson in
Google Scholar
PubMed
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
Search for other papers by Marcel van Herk in
Google Scholar
PubMed
deficiency in 6.9%. Luteinizing hormone and follicle-stimulating hormone (LH/FSH) deficiency was found in only 4.1% of the children following RT. In terms of dose-response, 78.8% of those who developed a growth hormone deficiency received a dose ≥ 40 Gy to
Department of Emergency Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Search for other papers by Lára Ósk Eggertsdóttir Claessen in
Google Scholar
PubMed
Search for other papers by Hafrún Kristjánsdóttir in
Google Scholar
PubMed
Department of Psychology, School of Social Sciences, Reykjavik University, Reykjavik, Iceland
Search for other papers by María Kristín Jónsdóttir in
Google Scholar
PubMed
School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland
Search for other papers by Sigrún Helga Lund in
Google Scholar
PubMed
Search for other papers by Ingunn Unnsteinsdóttir Kristensen in
Google Scholar
PubMed
Department of Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Search for other papers by Helga Ágústa Sigurjónsdóttir in
Google Scholar
PubMed
). Undiagnosed HP following mTBI can have serious physical and psychological consequences depending on which axes are affected ( 20 , 21 ). While untreated glucocorticoid deficiency (GCD) can be life-threatening, symptoms of growth hormone deficiency (GHD) may
Search for other papers by Ja Hye Kim in
Google Scholar
PubMed
Search for other papers by Yunha Choi in
Google Scholar
PubMed
Search for other papers by Soojin Hwang in
Google Scholar
PubMed
Search for other papers by Gu-Hwan Kim in
Google Scholar
PubMed
Search for other papers by Han-Wook Yoo in
Google Scholar
PubMed
Search for other papers by Jin-Ho Choi in
Google Scholar
PubMed
pubertal age 7 4 2 1 HH 6 4 2 1 SRT 6 4 2 1 † † Reversible Kallmann syndrome. AGA, appropriate for gestational age; GH, growth hormone; GHD, growth hormone deficiency; GnRH, gonadotropin
Search for other papers by Vanderlan O Batista in
Google Scholar
PubMed
Search for other papers by Michael Kellner in
Google Scholar
PubMed
Search for other papers by Roberto Salvatori in
Google Scholar
PubMed
Search for other papers by Walter Lisboa in
Google Scholar
PubMed
Search for other papers by André Faro in
Google Scholar
PubMed
Search for other papers by Lucas B Santos in
Google Scholar
PubMed
Search for other papers by Enaldo V Melo in
Google Scholar
PubMed
Search for other papers by Alécia A Oliveira-Santos in
Google Scholar
PubMed
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed
Search for other papers by Viviane C Campos in
Google Scholar
PubMed
Search for other papers by Cynthia S Barros-Oliveira in
Google Scholar
PubMed
Search for other papers by Elenilde G Santos in
Google Scholar
PubMed
Search for other papers by Nathalie O Santana in
Google Scholar
PubMed
Search for other papers by Keila R Villar-Gouy in
Google Scholar
PubMed
Search for other papers by Ângela C Leal in
Google Scholar
PubMed
Search for other papers by Rivia S Amorim in
Google Scholar
PubMed
Search for other papers by Davi A Oliveira Simões in
Google Scholar
PubMed
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed
2017 177 R85 – R97 . ( https://doi.org/10.1530/EJE-16-1047 ) 11 Aguiar-Oliveira MH & Bartke A . Growth hormone deficiency: health and longevity . Endocrine Reviews 2019 40 575 – 601 . ( https://doi.org/10.1210/er.2018-00216 ) 12 Falleti MG